News
Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder ...
AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending it now must do the same and invest more to protect its health sovereignty ...
Pascal Soriot, Director at Agilent Technologies (NYSE:A), reported an insider buy on May 23, according to a new SEC filing. What Happened: Soriot made a significant move by purchasing 1,677 shares ...
Pascal Soriot is CEO of pharmaceutical company AstraZeneca. As chair of the Sustainable Markets Initiative (SMI) Health System Task Force, Soriot brings together business leaders from across the ...
AstraZeneca’s Pascal Soriot is no stranger to shareholder scrutiny—especially when it comes to the longtime CEO’s pay. But the latest campaign against his re-election is nothing short of ...
Hosted on MSN2mon
Watch CNBC's full interview with AstraZeneca CEO Pascal Soriot on its $2.5 billion China investmentPascal Soriot, CEO of British pharmaceutical giant AstraZeneca, discusses the company's $2.5 billion investment in a new China research and development center. America’s Second-Richest Elected ...
Hello, everyone, and nice to see you again after our extended break. A little time away is always a good thing, but now we have returned to our usual routine. Of course, we are starting by firing ...
AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results
CEO Pascal Soriot said AstraZeneca is compliant with Chinese policies and is working closely with authorities following the detention. The probe centers around AstraZeneca’s eight or nine ...
AstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to almost double ...
Pascal Soriot, 65, fought off a takeover attempt of AstraZeneca Plc in the early stages of his 12-year run as chief executive officer before developing the company into a cancer drugs powerhouse ...
Pascal Soriot has led AstraZeneca as CEO since 2012, guiding the company’s transformation into a global leader in science-driven innovation with a strong pipeline and substantial growth.
What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission. The transaction's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results